CSL Seqirus in-licensed and supplied the vaccine in Australia under an agreement with MSD. The companies have a long history of partnering on vaccines, dating back to the 1990s. …
MSD regains Australian rights to supply and distribute its pneumococcal vaccine
July 1, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Committee recommends major overhaul of diabetes management and access
July 5, 2024 - - Latest News -
New report reveals strong growth in valuations of local life science companies
July 5, 2024 - - Latest News -
Merck’s record support for the Australian Multiple Sclerosis Community
July 5, 2024 - - Latest News -
CSL's gene therapy becomes the first funded via the UK's 'Innovative Medicines Fund'
July 5, 2024 - - Latest News -
New Zealand pharmacies to administer more childhood vaccinations
July 4, 2024 - - Latest News -
Patients gather in Canberra to call for access ahead of next week's PBAC meeting
July 4, 2024 - - Latest News -
Medicines Australia wants changes made to draft immunisation strategy
July 3, 2024 - - Latest News